GB2253859A - Use of bacteriophages to prevent microbial infestation - Google Patents
Use of bacteriophages to prevent microbial infestation Download PDFInfo
- Publication number
- GB2253859A GB2253859A GB9104277A GB9104277A GB2253859A GB 2253859 A GB2253859 A GB 2253859A GB 9104277 A GB9104277 A GB 9104277A GB 9104277 A GB9104277 A GB 9104277A GB 2253859 A GB2253859 A GB 2253859A
- Authority
- GB
- United Kingdom
- Prior art keywords
- phage
- use according
- foodstuff
- bacteriophages
- listeria
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
- 241001515965 unidentified phage Species 0.000 title claims abstract description 18
- 206010061217 Infestation Diseases 0.000 title abstract description 7
- 230000000813 microbial effect Effects 0.000 title description 4
- 239000007921 spray Substances 0.000 claims abstract description 11
- 235000013365 dairy product Nutrition 0.000 claims abstract description 6
- 241000186781 Listeria Species 0.000 claims description 18
- 235000013351 cheese Nutrition 0.000 claims description 15
- 238000000034 method Methods 0.000 claims description 15
- 240000002129 Malva sylvestris Species 0.000 claims description 7
- 235000006770 Malva sylvestris Nutrition 0.000 claims description 7
- 241000894007 species Species 0.000 claims description 6
- 230000008569 process Effects 0.000 claims description 5
- 241000233866 Fungi Species 0.000 claims description 4
- 238000002156 mixing Methods 0.000 claims description 4
- 238000004659 sterilization and disinfection Methods 0.000 claims description 3
- 208000035143 Bacterial infection Diseases 0.000 claims description 2
- 208000022362 bacterial infectious disease Diseases 0.000 claims description 2
- 238000002347 injection Methods 0.000 claims description 2
- 239000007924 injection Substances 0.000 claims description 2
- 241001112696 Clostridia Species 0.000 abstract description 3
- 241000186779 Listeria monocytogenes Species 0.000 abstract 1
- 238000002360 preparation method Methods 0.000 description 26
- 241000894006 Bacteria Species 0.000 description 15
- 238000004519 manufacturing process Methods 0.000 description 7
- 238000011282 treatment Methods 0.000 description 6
- 230000007613 environmental effect Effects 0.000 description 5
- 208000015181 infectious disease Diseases 0.000 description 5
- 239000000243 solution Substances 0.000 description 5
- 239000007788 liquid Substances 0.000 description 4
- 239000000047 product Substances 0.000 description 4
- 241000193403 Clostridium Species 0.000 description 3
- 230000000694 effects Effects 0.000 description 3
- 239000000203 mixture Substances 0.000 description 3
- 238000003860 storage Methods 0.000 description 3
- 239000000126 substance Substances 0.000 description 3
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 3
- 239000000654 additive Substances 0.000 description 2
- 230000001580 bacterial effect Effects 0.000 description 2
- 230000009286 beneficial effect Effects 0.000 description 2
- 230000009089 cytolysis Effects 0.000 description 2
- 230000006378 damage Effects 0.000 description 2
- 238000009826 distribution Methods 0.000 description 2
- 230000008030 elimination Effects 0.000 description 2
- 238000003379 elimination reaction Methods 0.000 description 2
- 239000000796 flavoring agent Substances 0.000 description 2
- 235000019634 flavors Nutrition 0.000 description 2
- 230000001320 lysogenic effect Effects 0.000 description 2
- 244000005700 microbiome Species 0.000 description 2
- 238000004806 packaging method and process Methods 0.000 description 2
- 239000000843 powder Substances 0.000 description 2
- 238000000108 ultra-filtration Methods 0.000 description 2
- 235000013618 yogurt Nutrition 0.000 description 2
- 206010000087 Abdominal pain upper Diseases 0.000 description 1
- 241000251468 Actinopterygii Species 0.000 description 1
- 229920001817 Agar Polymers 0.000 description 1
- 241000193452 Clostridium tyrobutyricum Species 0.000 description 1
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 description 1
- 241000588724 Escherichia coli Species 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 229930195725 Mannitol Natural products 0.000 description 1
- 238000011887 Necropsy Methods 0.000 description 1
- 206010058667 Oral toxicity Diseases 0.000 description 1
- 230000005856 abnormality Effects 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 235000019631 acid taste sensations Nutrition 0.000 description 1
- 231100000460 acute oral toxicity Toxicity 0.000 description 1
- 230000000996 additive effect Effects 0.000 description 1
- 239000000443 aerosol Substances 0.000 description 1
- 239000008272 agar Substances 0.000 description 1
- 239000003570 air Substances 0.000 description 1
- 235000019728 animal nutrition Nutrition 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 239000000969 carrier Substances 0.000 description 1
- 239000012876 carrier material Substances 0.000 description 1
- 238000001311 chemical methods and process Methods 0.000 description 1
- 239000002131 composite material Substances 0.000 description 1
- 239000012141 concentrate Substances 0.000 description 1
- 238000011109 contamination Methods 0.000 description 1
- 230000034994 death Effects 0.000 description 1
- 230000002939 deleterious effect Effects 0.000 description 1
- 239000008121 dextrose Substances 0.000 description 1
- 238000010790 dilution Methods 0.000 description 1
- 239000012895 dilution Substances 0.000 description 1
- 239000000428 dust Substances 0.000 description 1
- 238000000855 fermentation Methods 0.000 description 1
- 239000012467 final product Substances 0.000 description 1
- 235000019688 fish Nutrition 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 238000004108 freeze drying Methods 0.000 description 1
- 230000002538 fungal effect Effects 0.000 description 1
- 238000011534 incubation Methods 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 238000002372 labelling Methods 0.000 description 1
- 235000015250 liver sausages Nutrition 0.000 description 1
- 238000000464 low-speed centrifugation Methods 0.000 description 1
- 239000006166 lysate Substances 0.000 description 1
- 230000002101 lytic effect Effects 0.000 description 1
- 239000000594 mannitol Substances 0.000 description 1
- 235000010355 mannitol Nutrition 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 235000013622 meat product Nutrition 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 235000013336 milk Nutrition 0.000 description 1
- 239000008267 milk Substances 0.000 description 1
- 210000004080 milk Anatomy 0.000 description 1
- 231100000989 no adverse effect Toxicity 0.000 description 1
- 244000039328 opportunistic pathogen Species 0.000 description 1
- 231100000418 oral toxicity Toxicity 0.000 description 1
- 150000007524 organic acids Chemical class 0.000 description 1
- 235000005985 organic acids Nutrition 0.000 description 1
- 238000000053 physical method Methods 0.000 description 1
- 238000007747 plating Methods 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 235000013580 sausages Nutrition 0.000 description 1
- 239000002689 soil Substances 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 238000005507 spraying Methods 0.000 description 1
- 239000006228 supernatant Substances 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 230000009967 tasteless effect Effects 0.000 description 1
- 238000005199 ultracentrifugation Methods 0.000 description 1
- 235000013311 vegetables Nutrition 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23B—PRESERVATION OF FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES; CHEMICAL RIPENING OF FRUIT OR VEGETABLES
- A23B11/00—Preservation of milk or dairy products
- A23B11/60—Preservation of cheese or cheese preparations
- A23B11/65—Preservation of cheese or cheese preparations by addition of preservatives
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N63/00—Biocides, pest repellants or attractants, or plant growth regulators containing microorganisms, viruses, microbial fungi, animals or substances produced by, or obtained from, microorganisms, viruses, microbial fungi or animals, e.g. enzymes or fermentates
- A01N63/40—Viruses, e.g. bacteriophages
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23B—PRESERVATION OF FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES; CHEMICAL RIPENING OF FRUIT OR VEGETABLES
- A23B2/00—Preservation of foods or foodstuffs, in general
- A23B2/70—Preservation of foods or foodstuffs, in general by treatment with chemicals
- A23B2/725—Preservation of foods or foodstuffs, in general by treatment with chemicals in the form of liquids or solids
- A23B2/729—Organic compounds; Microorganisms; Enzymes
- A23B2/783—Microorganisms; Enzymes
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Zoology (AREA)
- Health & Medical Sciences (AREA)
- Wood Science & Technology (AREA)
- General Health & Medical Sciences (AREA)
- Virology (AREA)
- Chemical & Material Sciences (AREA)
- Polymers & Plastics (AREA)
- Food Science & Technology (AREA)
- Agronomy & Crop Science (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- Pest Control & Pesticides (AREA)
- Plant Pathology (AREA)
- Dentistry (AREA)
- Environmental Sciences (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Food Preservation Except Freezing, Refrigeration, And Drying (AREA)
Abstract
Bacteriophages are used in areas where foodstuffs are prepared and stared to treat or prevent infestation by harmful microbes, e.g. Listeria monocytogenes or clostridia sp. in dairy environments. The phage may be applied as a spray at a concentration of about 10<2> to 10<11> pfu.
Description
ENVIRONMENTAL SPRAYS
The present invention relates to preparations for the prevention and treatment of microbial infestations in food-stuffs.
Food-stuffs are susceptible to a wide variety of microbial infestations. These are rarely beneficial and frequently harmful. Those of a harmful nature can cause mild tainting of the food-stuff, or illness ranging from mild stomach ache to death in the consumer, always assuming that the food is not rendered completely inedible.
Milk products, and especially cheese, are particularly prone to infection by such organisms as
Listeria, which is an opportunist pathogen, and
Clostridia which can result in an unpleasant acid taste which may be combined with uncontrolled gas production to cause an unsightly, deformed product.
Microbial infestation need not always be undesirable. The production of certain cheeses, for example, is totally reliant on the presence of certain fungi, and yoghurt is a thick culture of harmless bacteria.
Listeria organisms are found effectively everywhere, such as in the soil, water and air. In dairy environments, such as in the manufacture of cheese,
Listeria monocytoqenes has been shown to be present in drains and on wet floors in preparation areas as well as in floor samples in the 'maturing' rooms.
Listeria organisms can also be a nuisance in the manufacture of blue cheeses which, once made, are injected with specific fungal species (to make the 'blue' veining, for example, Stiltons) and this is a problem entry point for Listeria.
Further, the mixing of cheeses to make soft 'blended' varieties is particularly at risk from environmental Listeria, most of the contamination of these cheeses arising at the time of blending.
Normal disinfection of the dairies does not always eradicate all Listeria, particularly in inaccessible places, such as drains.
It has now been discovered that the use of bacteriophages in areas where foodstuffs are prepared and stored can prevent infestation by harmful microbes.
Thus, in a first aspect of the present invention, there is provided the use of at least one species of bacteriophage in an area where a foodstuff is prepared or stored to treat or prevent bacterial infection in the foodstuff.
The foodstuff may be any that is prone to infection by bacteria, and the bacteriophage may be used at any time from commencement of preparation of the foodstuff, for example, to final consumption. The foodstuff may be such as meat products, such as pate or sausages, or fish and/or vegetable preparations, for example. However, the use of the invention is generally preferred to be in connection with a dairy product, such as yogurt, but especially cheese.
The bacteriophage (also referred to as phage herein) may be used in any suitable manner to treat of prevent infestation. The phage may be applied as a solution or dry powder, for example, to surfaces in the relevant areas, or may be applied as a spray or dust. A fine spray or other form which can be distributed in the atmosphere of the preparation or storage areas, without settling too rapidly, is particularly beneficial, in that this will allow the phage to spread out and to reach areas which cannot normally be reached directly, such as drains.
Distribution of a suitable phage preparation in the atmosphere or other parts of the preparation or storage environment may be by any suitable means. Industrial sprayers or aerosols may be employed to disperse a fine solution of the phage, and these may be aided, for example, by suitable means to agitate the air to further ensure adequate distribution of the phage.
Bacteria against which phages may be used in the use of the present invention may be any that infest foodstuffs. Clostridium and Listeria are general examples of harmful bacteria, with Listeria, especially
L. monocvtoqenes, being a problem in the manufacture of cheeses. As used throughout this specification, where
Listeria is used, this term also encompasses other bacteria which infect foodstuffs. Likewise, where the term cheese is used, other foodstuffs are also to be understood.
An environmental spray containing listeriaphages to reduce the incidence levels of Listeria in the atmosphere of cheese-making dairies is preferred, and an environmental spray may be used at any stage in the preparation of cheese, but particularly when there is risk of exposure to Listeria. Particular occasions where sprays may be used have been described above. For example, the spray may be used before or following normal disinfection, before the process of blending cheeses, or before the injection of 'blue' fungi.
An environmental listeriaphage spray may be produced as a concentrated liquid or a soluble powder (say, in dextrose) - to be mixed with water and added to any propriety spraying equipment, at levels of 102 to 1011.
The product may contain any number of phage types which are active against as many strains of Listeria, especially L. monocytocrenes as possible, to increase the efficacy of the phage spray with respect to the reduction or elimination of as many strains as possible.
The present invention also provides preparations containing at least one variety of bacteriophage and a suitable carrier therefor for use as described.
Bacteriophages are highly host-specific. Extremely rapid multiplication within the host cell occurs leading to the destruction of the cell (lysis) and the release of up to 20,000 new phages, each capable of further infection. Phages are essentially non-living outside the host cell and, therefore, can exhibit very considerable longevity, making them particularly useful in preparations according to the present invention.
It will be appreciated that as bacteriophages are highly specific in the organisms they can infect, any one variety of phage will only infect one species of bacterium and, frequently, only selected strains of that species. There is thus no danger to the consumer of being infected by the phage.
A particular advantage in the use of phages according to the present invention is that, with only extremely small quantities of phage being required for efficacy, there is no adverse effect on flavour, should the phage get into the foodstuff. Furthermore, as phages only infect highly specific organisms, no propagation of phage can take place in the absence of the host bacterium, so the cheese remains completely unaffected by their presence.
A disadvantage of the antibacterial treatments of the art generally lies in their inability to reach all the harmful bacteria. Such problems are further compounded by the requirement not to get into the foodstuff, as this may both have a deleterious effect on flavour and also kill bacteria or fungi which may be an important part of the foodstuff, or in its preparation.
Phages do not suffer from these problems, as they may be freely dispersed in the preparation or storage areas and may be allowed to contact the foodstuff, being both tasteless and harmless. Phages provide the solution to the problem and can be selected against any bacterium as required.
Thus, in a further aspect of the present invention there is provided the use or process as defined above wherein the bacteriophage(s) is selected according to host bacterium specificity.
It will be appreciated that, while lysogenic phages can be used in accordance with the invention, the use of lytic phages is generally preferred, as infection results in the rapid destruction of the unwanted bacterial host.
Bacteria are known to be able to develop resistance to phage infection. The present invention, therefore, further provides a use or process as described above wherein the preparation comprises at least two strains of phage specific for one host. If the target micro-organism develops a resistance to one phage, or the phage becomes lysogenic, elimination of the unwanted organism still occurs.
Still more preferable is the 'rotation' of phages.
For example, in the case where three phages are available against Clostridia spp., then three preparations of different phage pairs are available for use in successive treatments to minimise the risk of resistance developing.
As used herein, 'rotation' means varying the bacteriophage composition of preparations according to the present invention with different batches of cheese prepared in the same locale. Such variation need not be cyclical, or even regular, provided that different compositions are used occasionally to prevent resistance developing.
Preparations according to the present invention may contain phages specific for several different species of bacterium. A suitable treatment may contain phages specific for two Clostridium and one Listeria species, for example.
Listeria spp. are particularly susceptible to treatment according to the present invention. Anaerobes are generally significantly less efficient than aerobes, as life processes must be restricted to essentials to allow effective exploitation of the anaerobic environment. Thus, while the likes of E. coli have highly sophisticated mechanisms against phage attack, anaerobes are generally less able to generate a defence.
Suitable bacteriophages for use according to the present invention may be isolated from natural sources, preferably using known bacteriophage enhancement techniques [c.f. Betz, J.V., & Anderson, K.E., (1983),
J. Bact., 87, 408]. Bacteriophages so isolated may be characterised as to their host specificity by known techniques.
Suitable quantities of phage for use according to the present invention may be obtained, for example, by a batch technique, wherein a culture of host bacterium is grown nearly to capacity and then seeded with phage.
After a suitable time has elapsed to allow maximal phage propagation, the culture is further lysed by chemical or physical techniques, if required, and the lysate spun down. The phage-bearing supernatant may then be further purified, for example by ultrafiltration, and concentrated (freeze-drying, for instance). The resulting preparation can be used directly or further combined with other ingredients to aid in packaging, end-use etc.
Large-scale commercial production of Listeriaspecific phages may involve initial anaerobic fermentation of the host Listeria species, preferably in optimal submerged culture conditions for a time adequate to achieve logarithmic growth of the culture. Specific phage preparations are then introduced to the culture and incubation continued until maximal lysis can be demonstrated. Downstream recovery of such a phage preparation from solution may be effected by initial low-speed centrifugation to remove any remaining bacterial cells and debris, and the phage purified and concentrated by ultracentrifugation and ultrafiltration techniques. The resulting concentrated phage preparation can be cryoprotected and freeze-dried by techniques well-known in the art, or preferably plated onto, or mixed with, a suitable carrier material and air- or vacuum-dried as appropriate.Bacteriophages can also be encapsulated in acid-resistant biodegradable gums to provide a composite additive product optionally containing organic acids. Typical activity levels of phages prepared according to the above methods range l071012 from 107-1012 pfu/gram of concentrate according to the particular phage morphology.
Preparations according to the present invention suitably contain at least two varieties of phage, optionally specific for more than one family of bacterium, as required. The preparations may be liquid or solid according to requirements. Liquid preparations may be simple suspensions of phage in water, but preferably further comprise a suitable carrier.
Suitable carriers may, for example be sugar-based, such as mannitol, but may comprise any suitable substance known in the art.
Liquid preparations may be prepared from any of the preparations generally available for similar use, a suitable quantity of phage being added. In the alternative, a more concentrated 'stock' solution may be prepared for later dilution.
In order to determine phage activity in the final product, as well as during preparation, total specific phage counts may be undertaken using, for example, the double agar layer plating technique for plaque production, employing the host microbial species in each case. The method described by Adams, M.H., in "Bacteriophages" (Interscience Publishers (1959)) is suitable for this purpose.
The following Example is for illustration purposes only, and is not intended to limit the scope of the present invention in any way.
Example Toxicolosical Trial in the Rat
A single dose oral toxicity study in the rat was performed. The procedure used met the requirements of the limit test for acute oral toxicity described in
Annex V of the EEC Commission Directive relating to the classification, packaging and labelling of dangerous substances. This is an acceptable method in the assessment of additives in animal nutrition.
The test material was a mixture of equal concentration of bacteriophages specific to Clostridium sporoqenes and to Clostridium tyrobutyricum at a 10 combined level of 2 x 10 pfu/gram. This was administered as a single oral dose at a level of 2000 mg/kg live weight. In all cases no effects of treatment were observed and no abnormalities revealed at necropsy on termination of the study.
Claims (10)
1. The use of at least one species of bacteriophage in an area where a foodstuff is prepared or stored to treat or prevent bacterial infection in the foodstuff.
2. Use according to claim 1, wherein the foodstuff is a dairy product.
3. Use according to claim 1 or 2, wherein the foodstuff is cheese.
4. Use according to claim 3, wherein the phage is used before or following normal disinfection, before the process of blending cheeses, or before the injection of fungi.
5. Use according to any preceding claim, wherein the phage is applied as a spray.
6. Use according to any preceding claim, wherein the phage is used in concentrations of about 102 to about 1011 pfu.
pfu.
7. Use according to any preceding claim wherein more than one phage variety is used.
8. Use according to any preceding claim, wherein the phage is specific for a Listeria species.
9. Use according to claim 8, wherein the Listeria species is L. monocvtoqenes.
10. Use according to any preceding claim, wherein the variety of phage used is changed from time to time in the said area.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB9104277A GB2253859A (en) | 1991-02-28 | 1991-02-28 | Use of bacteriophages to prevent microbial infestation |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB9104277A GB2253859A (en) | 1991-02-28 | 1991-02-28 | Use of bacteriophages to prevent microbial infestation |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| GB9104277D0 GB9104277D0 (en) | 1991-04-17 |
| GB2253859A true GB2253859A (en) | 1992-09-23 |
Family
ID=10690778
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| GB9104277A Withdrawn GB2253859A (en) | 1991-02-28 | 1991-02-28 | Use of bacteriophages to prevent microbial infestation |
Country Status (1)
| Country | Link |
|---|---|
| GB (1) | GB2253859A (en) |
Cited By (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2001050866A2 (en) * | 2000-01-11 | 2001-07-19 | Intralytix, Inc. | Method and device for sanitation using bacteriophages |
| WO2004004495A1 (en) * | 2002-07-08 | 2004-01-15 | Exponential Biotherapies, Inc. | Virulent phages to control listeria monocytogenes in foodstuffs and in food processing plants |
| US6942858B1 (en) * | 1996-04-15 | 2005-09-13 | Nymox Corporation | Compositions containing bacteriophages and methods of using bacteriophages to treat infections |
| US7232564B2 (en) | 2001-07-18 | 2007-06-19 | Instytut Immunologii I Terapii Doswiadczal-Nej Pan | Methods of polyvalent bacteriophage preparation for the treatment of bacterial infections |
| EP2143729A1 (en) * | 2008-07-07 | 2010-01-13 | Hyglos Invest GmbH | New enzymatic active enzyme against Clostridium |
| WO2010036132A1 (en) | 2008-09-29 | 2010-04-01 | Instytut Immunologii i Terapii Doświadczalnej PAN | Novel bacteriophage strains for the treatment of bacterial infections, especially drug resistant strains of the genus enterococcus |
| WO2011162626A1 (en) | 2010-06-20 | 2011-12-29 | Instytut Immunologii i Terapii Doświadczalnej PAN | Novel strains of bacteriophages for the treatment of bacterial infections, particularly by strains of drug-resistant bacteria of the genus stenotrophomonas |
| US8956628B2 (en) | 2007-12-13 | 2015-02-17 | Zoetis Products Llc | Bacteriophage preparations and method of use thereof |
Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0414304A2 (en) * | 1989-08-21 | 1991-02-27 | Unilever N.V. | Aqueous antibacterial compositions comprising surfactant and bacteriophage |
-
1991
- 1991-02-28 GB GB9104277A patent/GB2253859A/en not_active Withdrawn
Patent Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0414304A2 (en) * | 1989-08-21 | 1991-02-27 | Unilever N.V. | Aqueous antibacterial compositions comprising surfactant and bacteriophage |
Cited By (19)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6942858B1 (en) * | 1996-04-15 | 2005-09-13 | Nymox Corporation | Compositions containing bacteriophages and methods of using bacteriophages to treat infections |
| US7459272B2 (en) | 2000-01-11 | 2008-12-02 | Intralytix, Inc. | Reduction in bacterial colonization by administering bacteriophage compositions |
| WO2001050872A2 (en) * | 2000-01-11 | 2001-07-19 | Intralytix, Inc. | Method for produce sanitation using bacteriophages |
| WO2001050872A3 (en) * | 2000-01-11 | 2001-12-20 | Intralytix Inc | Method for produce sanitation using bacteriophages |
| WO2001050866A3 (en) * | 2000-01-11 | 2002-02-07 | Intralytix Inc | Method and device for sanitation using bacteriophages |
| WO2001050866A2 (en) * | 2000-01-11 | 2001-07-19 | Intralytix, Inc. | Method and device for sanitation using bacteriophages |
| US6699701B1 (en) | 2000-01-11 | 2004-03-02 | Intralytix, Inc. | Method and device for sanitation using bacteriophages |
| EP1421855A2 (en) * | 2000-01-11 | 2004-05-26 | Intralytix Inc. | Method and device for sanitation using bacteriophages |
| EP1421855A3 (en) * | 2000-01-11 | 2004-07-14 | Intralytix Inc. | Method and device for sanitation using bacteriophages |
| US8003323B2 (en) | 2000-01-11 | 2011-08-23 | Intralytix, Inc. | Reduction in bacterial colonization by administering bacteriophage compositions |
| US7232564B2 (en) | 2001-07-18 | 2007-06-19 | Instytut Immunologii I Terapii Doswiadczal-Nej Pan | Methods of polyvalent bacteriophage preparation for the treatment of bacterial infections |
| WO2004004495A1 (en) * | 2002-07-08 | 2004-01-15 | Exponential Biotherapies, Inc. | Virulent phages to control listeria monocytogenes in foodstuffs and in food processing plants |
| US7438901B2 (en) | 2002-07-08 | 2008-10-21 | Exponential Biotherapies, Inc. | Virulent phages to control Listeria monocytogenes in foodstuffs and in food processing plants |
| US8034552B2 (en) | 2002-07-08 | 2011-10-11 | E.B.I. Food Safety B.V. | Virulent phages to detect Listeria monocytogenes in foodstuffs and in food processing plants |
| US8956628B2 (en) | 2007-12-13 | 2015-02-17 | Zoetis Products Llc | Bacteriophage preparations and method of use thereof |
| EP2143729A1 (en) * | 2008-07-07 | 2010-01-13 | Hyglos Invest GmbH | New enzymatic active enzyme against Clostridium |
| WO2010003943A1 (en) * | 2008-07-07 | 2010-01-14 | Profos Ag | New enzymatic active enzyme against clostridium |
| WO2010036132A1 (en) | 2008-09-29 | 2010-04-01 | Instytut Immunologii i Terapii Doświadczalnej PAN | Novel bacteriophage strains for the treatment of bacterial infections, especially drug resistant strains of the genus enterococcus |
| WO2011162626A1 (en) | 2010-06-20 | 2011-12-29 | Instytut Immunologii i Terapii Doświadczalnej PAN | Novel strains of bacteriophages for the treatment of bacterial infections, particularly by strains of drug-resistant bacteria of the genus stenotrophomonas |
Also Published As
| Publication number | Publication date |
|---|---|
| GB9104277D0 (en) | 1991-04-17 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE60216614T2 (en) | COMPOSITION WITH BACTERIOSTATIC AND BACTERICIDAL PROPERTIES AGAINST BACTERIAL SPORTS AND CELLS AND METHOD FOR USE THEREOF FOR THE TREATMENT OF FOODSTUFFS | |
| Scannell et al. | An effective lacticin biopreservative in fresh pork sausage | |
| Delves-Broughton et al. | Applications of the bacteriocin, nisin | |
| ES2226686T3 (en) | FOOD PACKING FILM AND METHOD FOR TREATMENT OF FOOD SURFACE. | |
| US5006347A (en) | Process for retarding bacterial growth in cheese | |
| AU2002320466A1 (en) | Composition having bacteristatic and bactericidal activity against bacterial spores and vegetative cells and process for treating foods therewith | |
| EP0397228B1 (en) | Decontamination process for non-liquid food product, particularly cheese and composition for the same | |
| CA2046452A1 (en) | Compositions having improved antibacterial properties and use of such compositions in suppressing growth of micro-organisms, e.g. listeria bacteria | |
| CN103651742A (en) | Biological preservative with food preservation effect and application thereof | |
| CA2362202A1 (en) | Adduct having an acidic solution of sparingly-soluble group iia complexes | |
| KR20020035478A (en) | Microbially resistant compositions | |
| US9066521B2 (en) | Enhanced preservation of processed food | |
| AU764855B2 (en) | Broad-range antibacterial composition | |
| EP0290295B1 (en) | Antimicrobial preparations | |
| GB2253859A (en) | Use of bacteriophages to prevent microbial infestation | |
| AU2016383699A1 (en) | Systems, methods, and compositions related to using non-live-bacteria preparations to promote food safety and preservation | |
| Notermans et al. | Use of preservatives to delay toxin formation by Clostridium botulinum (type B, strain Okra) in vacuum-packed, cooked potatoes | |
| McIntyre et al. | Biocontrol of foodborne bacteria | |
| De Candia et al. | Antimicrobial activity of processed spices used in traditional Southern Italian sausage processing | |
| US20040265289A1 (en) | Composition | |
| Lopes | Susceptibility of antibiotic-resistant and antibiotic-sensitive foodborne pathogens to acid anionic sanitizers | |
| US20040091470A1 (en) | Use of bacterial phage associated lytic enzymes to prevent food poisoning | |
| WO1990003122A1 (en) | Antimicrobial preparations | |
| WO2000038545A1 (en) | Antimicrobial treatment of sausage casings | |
| Enan | Inhibition of Clostridium perfringens LMG11264 in meat samples of chicken, turkey and beef by the bacteriocin plantaricin UG1 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| WAP | Application withdrawn, taken to be withdrawn or refused ** after publication under section 16(1) |